Note*: This report requires 7-10 business days to complete.
DelveInsight’s Chronic Obstructive Pulmonary Disease (COPD) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Chronic Obstructive Pulmonary Disease (COPD) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Chronic Obstructive Pulmonary Disease (COPD) till 2023.
Key Coverage and Benefits
• The report will help in developing business strategies by understanding the trends shaping and driving the global Chronic Obstructive Pulmonary Disease (COPD) market.
• Identifying patient populations in the global “Chronic Obstructive Pulmonary Disease (COPD)market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Chronic Obstructive Pulmonary Disease (COPD) therapeutics in each of the markets covered.
• To understand the future market competition in the global Chronic Obstructive Pulmonary Disease (COPD) therapeutics market and Insightful review of the key market drivers and barriers.
Scope
• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
• It also provides Chronic Obstructive Pulmonary Disease (COPD) for United States, EU5 and Japan from 2013 and forecasted Market to 2023.
'
Table of Contents
• Chronic Obstructive Pulmonary Disease (COPD) overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Chronic Obstructive Pulmonary Disease (COPD) Market
• Global Epidemiology of Chronic Obstructive Pulmonary Disease (COPD) Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Chronic Obstructive Pulmonary Disease (COPD) Drug Sales (USD Millions)-2023
• Table 6: Global Epidemiology of Chronic Obstructive Pulmonary Disease (COPD) (2013-2023)
• Table 7: Chronic Obstructive Pulmonary Disease (COPD) Global Market (USD Millions), (2013-2015)
• Table 8: Chronic Obstructive Pulmonary Disease (COPD) Global Market (USD Millions), (2016-2023)
• Table 9: Chronic Obstructive Pulmonary Disease (COPD) US Market (USD Millions), (2013-2015)
• Table 10: Chronic Obstructive Pulmonary Disease (COPD) US Market (USD Millions), (2016-2023)
• Table 11: Chronic Obstructive Pulmonary Disease (COPD) Germany Market (USD Millions), (2013-2015)
• Table 12: Chronic Obstructive Pulmonary Disease (COPD) Germany Market (USD Millions), (2016-2023)
• Table 13: Chronic Obstructive Pulmonary Disease (COPD) United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Chronic Obstructive Pulmonary Disease (COPD) United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Chronic Obstructive Pulmonary Disease (COPD) France Market (USD Millions), (2013-2015)
• Table 16: Chronic Obstructive Pulmonary Disease (COPD) France Market (USD Millions), (2016-2023)
• Table 17: Chronic Obstructive Pulmonary Disease (COPD) Italy Market (USD Millions), (2013-2015)
• Table 18: Chronic Obstructive Pulmonary Disease (COPD) Italy Market (USD Millions), (2016-2023)
• Table 19: Chronic Obstructive Pulmonary Disease (COPD) Spain Market (USD Millions), (2013-2015)
• Table 20: Chronic Obstructive Pulmonary Disease (COPD) Spain Market (USD Millions), (2016-2023)
• Table 21: Chronic Obstructive Pulmonary Disease (COPD) Japan Market (USD Millions), (2013-2015)
• Table 22: Chronic Obstructive Pulmonary Disease (COPD) Japan Market (USD Millions), (2016-2023)
• Table 23: Chronic Obstructive Pulmonary Disease (COPD) ROW Market (USD Millions), (2013-2015)
• Table 24: Chronic Obstructive Pulmonary Disease (COPD) ROW Market (USD Millions), (2016-2023)
List of Figures
• Figure 1: Chronic Obstructive Pulmonary Disease (COPD) Drug Sales (USD Millions)-2023
• Figure 2: Global Epidemiology of Chronic Obstructive Pulmonary Disease (COPD) (2013-2023)
• Figure 3: Chronic Obstructive Pulmonary Disease (COPD) Global Market (USD Millions), (2013-2015)
• Figure 4: Chronic Obstructive Pulmonary Disease (COPD) Global Market (USD Millions), (2016-2023)
• Figure 5: Chronic Obstructive Pulmonary Disease (COPD) US Market (USD Millions), (2013-2015)
• Figure 6: Chronic Obstructive Pulmonary Disease (COPD) US Market (USD Millions), (2016-2023)
• Figure 7: Chronic Obstructive Pulmonary Disease (COPD) Germany Market (USD Millions), (2013-2015)
• Figure 8: Chronic Obstructive Pulmonary Disease (COPD) Germany Market (USD Millions), (2016-2023)
• Figure 9: Chronic Obstructive Pulmonary Disease (COPD) United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Chronic Obstructive Pulmonary Disease (COPD) United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Chronic Obstructive Pulmonary Disease (COPD) France Market (USD Millions), (2013-2015)
• Figure 12: Chronic Obstructive Pulmonary Disease (COPD) France Market (USD Millions), (2016-2023)
• Figure 13: Chronic Obstructive Pulmonary Disease (COPD) Italy Market (USD Millions), (2013-2015)
• Figure 14: Chronic Obstructive Pulmonary Disease (COPD) Italy Market (USD Millions), (2016-2023)
• Figure 15: Chronic Obstructive Pulmonary Disease (COPD) Spain Market (USD Millions), (2013-2015)
• Figure 16: Chronic Obstructive Pulmonary Disease (COPD) Spain Market (USD Millions), (2016-2023)
• Figure 17: Chronic Obstructive Pulmonary Disease (COPD) Japan Market (USD Millions), (2013-2015)
• Figure 18: Chronic Obstructive Pulmonary Disease (COPD) Japan Market (USD Millions), (2015-2023)
• Figure 19: Chronic Obstructive Pulmonary Disease (COPD) ROW Market (USD Millions), (2013-2015)
• Figure 20: Chronic Obstructive Pulmonary Disease (COPD) ROW Market (USD Millions), (2016-2023)
• GlaxoSmithKline Plc
• C. H. Boehringer Sohn AG & Co. KG
• AstraZeneca Plc
• Novartis AG
• Chiesi Farmaceutici SpA
• Pfizer Inc.
• Allergan Plc
• Quintiles Transnational Holdings Inc.
• Takeda Pharmaceutical Company Limited
• Almirall S.A.
